The potential impacts of HLA-DM proteins’ efficiency in the HLA class II peptide selection have been indicated in several autoimmune diseases’ development, such as diabetes and rheumatoid arthritis [40,41]. This evidence concerns the gene HLA-DMA and autoimmune disease.